Philip Kiaer Ahring (Philip Kiær Ahring, Philip K Ahring)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Intellectual Disability

Binding Protein

Saccharomyces Cerevisiae

Top Venues

Brain : a journal of neurology

British journal of pharmacology

The Journal of general physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Nathan L Absalom, Serene El-Kamand, Han Chow Chua, Philip Kiaer Ahring
Follow the allosteric transitions to predict variant pathogenicity: a channel-specific approach. Brain : a journal of neurology 147 (5) (2024)
Nathan L Absalom, Serene El-Kamand, Han Chow Chua, Philip Kiaer Ahring
Follow the allosteric transitions to predict variant pathogenicity: a channel-specific approach. Brain : a journal of neurology (2024)
Nathan L Absalom, Serene El-Kamand, Han Chow Chua, Philip Kiaer Ahring
Follow the allosteric transitions to predict variant pathogenicity: a channel-specific approach. Brain : a journal of neurology 147 (5) (2024)
Susan X N Lin, Philip Kiaer Ahring, Angelo Keramidas, Vivian W Y Liao, Rikke S Møller, Mary Chebib, Nathan L Absalom
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity. Brain : a journal of neurology (2023)
Nathan L Absalom, Susan X N Lin, Vivian Wan Yu Liao, Han Chow Chua, Rikke Steensjerre Moller, Mary Chebib, Philip Kiaer Ahring
GABA A receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variants. Journal of neurochemistry (2023)
Philip Kiaer Ahring, Vivian Wan Yu Liao, Susan X N Lin, Nathan L Absalom, Mary Chebib, Rikke Steensjerre Moller
The de novo GABRA4 p.Thr300Ile variant found in a patient with early-onset intractable epilepsy and neurodevelopmental abnormalities displays gain-of-function traits. Epilepsia 63 (9) (2022)
Nathan L Absalom, Vivian Wan Yu Liao, Katrine Marie Johannesen, Elena Gardella, Julia Jacobs, Gaëtan Lesca, Zeynep Gokce-Samar, Alexis A Arzimanoglou, Shimriet Zeidler, Pasquale Striano, Pierre Meyer, Ira Benkel-Herrenbrueck, Inger-Lise Mero, Jutta Rummel, Mary Chebib, Rikke Steensjerre Moller, Philip Kiaer Ahring
Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies. Nature communications 13 (1) (2022)
Vivian Wan Yu Liao, Mary Chebib, Philip Kiaer Ahring
Efficient expression of concatenated α1β2δ and α1β3δ GABAA receptors, their pharmacology and stoichiometry. British journal of pharmacology 178 (7) (2021)
Vivian Wan Yu Liao, Ali Saad Kusay, Thomas Balle, Philip Kiaer Ahring
Heterologous expression of concatenated nicotinic ACh receptors: Pros and cons of subunit concatenation and recommendations for construct designs. British journal of pharmacology 177 (18) (2020)
Vivian Wan Yu Liao, Han Chow Chua, Natalia Magdalena Kowal, Mary Chebib, Thomas Balle, Philip Kiaer Ahring
Concatenated γ-aminobutyric acid type A receptors revisited: Finding order in chaos. The Journal of general physiology 151 (6) (2019)
Philip Kiaer Ahring, Vivian Wan Yu Liao, Thomas Balle
Concatenated nicotinic acetylcholine receptors: A gift or a curse? The Journal of general physiology 150 (3) (2018)